Jeffrey Tarrand, BS, MD, MS
Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div
Present Title & Affiliation
Primary Appointment
Adjunct Professor, Department of Biology, Division of Pathology-Lab Medicine Div, Baylor University, Waco, TX
Professor, Department of Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Adjunct Assistant Professor, Department of Microbiology, University of Texas, Austin, TX
Adjunct Professor, Department of Program in Clinical Laboratory Sciences, University of Texas M.D. Anderson Cancer Center, School of Allied Health, Houston, TX
Adjunct Professor, Department of Program in Clinical Laboratory Sciences, University of Texas M.D. Anderson Cancer Center, School of Allied Health, Houston, TX
Chief, Section of Clinical Microbiology and Virology, Department of Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Adjunct Professor, Department of Biology, Baylor University, Waco, TX
Adjunct Assistant Professor, Department of Microbiology, University of Texas, Austin, TX
Professor, Department of Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Pathologist and Associate Professor, Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1981 | University of Virginia, Charlottesville, Virginia, US, MD |
| 1977 | Virginia Polytechnic Institute, Blacksburg, Virginia, US, Microbiology, M.S |
| 1975 | Virginia Polytechnic Institute, Blacksburg, Virginia, US, Biology, BS |
Postgraduate Training
| 2006-2011 | Clinical Safety and Effectiveness, UT MD Anderson Cancer Center, Houston, Texas |
| 2004-2011 | Faculty Leadership Academy, Cohort V, UT MD Anderson Cancer Center, Houston, Texas |
| 1997-1997 | Executive Development Program “Executive Excellence,”, Rice University, Houston, Texas |
| 1989-1989 | Course in Infection control and Hospital Epidemiology, Albert Einstein College of Medicine, New York, New York |
| 1988-1988 | Post Graduate Fellowship in Clinical Microbiology, Barnes Hospital, St. Louis, Missouri |
| 1987-1987 | Post Graduate Research Fellowship in Immunology, Washington University, St. Louis, Missouri |
| 1986-1986 | Post Graduate Fellowship in Basic Microbiology, University of Virginia, Charlottesville, Virginia |
| 1985-1985 | Post Graduate Fellowship in Clinical Microbiology, University of Virginia, Charlottesville, Virginia |
| 1984-1984 | Post Graduate Residency in Pathology, University of Virginia, Charlottesville, Virginia |
Licenses & Certifications
| 1990 | American Board of Pathology, Clinical Pathology |
| 1988 | Texas Medical Board |
| 1982 | National Board of Medical Examiners, Part III |
| 1981 | National Board of Medical Examiners, Part II |
| 1980 | National Board of Medical Examiners, Part I |
Experience & Service
Faculty Academic Appointments
Adjunct Faculty, UT Health Science, Graduate School of Biomedical Science, Houston, TX, 2009 - 2011
Associate Pathologist, Department of Laboratory Medicine, Department of Division of Pathology and Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX, 1994
Assistant Professor of Laboratory Medicine and Assistant Professor of Pathology, University of Texas M. D Anderson Cancer Center, Houston, TX, 1988 - 1994
Administrative Appointments/Responsibilities
Clinical Fellowship in chemical pathology Laboratories, University of Texas M. D. Anderson Cancer Center, Houston, TX, 1998
Medical Director for the Diagnostic Center, Department of Division of Pathology and Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX, 1998
Acting Medical Director for the Diagnostic Center, Department of Division of Pathology and Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX, 1996 - 1998
Medical Director of “Program in Medical Technology,”, Department of Allied Health Program, University of Texas M. D. Anderson Cancer Center, Houston, TX, 1995
Chief, Section of Clinical Microbiology and Virology, Department of Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, 1994 - Present
Institutional Infection Control Officer – Laboratories, University of Texas M. D. Anderson Cancer Center, Houston, TX, 1993
Associate Director, Texas Medical Center Postdoctoral Fellowship Program in Medical Microbiology and Public Health, Houston, TX, 1992 - 2002
Acting Chief, Section of Clinical Microbiology, Department of Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX, 1988 - 1993
Acting Chief, Infection Control Services, Department of Division of Pathology and Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX, 1988 - 1993
Other Professional Positions
CAP Team Leader, Clinical and Anatomic Pathology, Scott and White, Temple, TX, 2003
Member, Tanox Inc, Houston, TX, 2001 - 2003
Medical Students Research, 1999
King Foundation Summer Research Students, 1998
CAP Inspector, Nichols Institute, Houston, TX, 1993
CAP Inspector, MSI Laboratory, Houston, TX, 1993
CAP Inspector, Medical Center Hospital Laboratories, San Antonio, TX, 1992
Alternate, 1991 - 1994
CAP Inspector, Audie L. Murphy Veterans Hospital, San Antonio, TX, 1990
Member, 1990 - 1994
CAP Inspector, University of Texas Southwestern Medical Center, Dallas, TX, 1989
Member, Institutional Committee Activities, Product Standards and Evaluation Committee, MD Anderson Cancer Center, 1989 - 1991
CAP Inspector, Medical Center Hospital, San Antonio, TX, 1989
Alternate Member, 1989 - 1994
Extramural Institutional Committee Activities
Ad Hoc Subcommittee Leader, Institutional Manufacturing Oversight Advisory Committee (IMOAC), The University of Texas MD Anderson Cancer Center, 2013 - Present
CAP Member, Microbiology Resource Committee, The University of Texas MD Anderson Cancer Center, 2011 - Present
Ad Hoc Subcommittee Leader, Policy Review: Safety Precautions for Staff and Visitors of Patients Being Treated with Aerosolized Ribavirin, The University of Texas MD Anderson Cancer Center, 2005
Ad Hoc Subcommittee Leader, Working group – Terrorism response and preparedness planning, The University of Texas MD Anderson Cancer Center, 2002
Ad Hoc Subcommittee Leader, Recommendation for Modified TB Skin Testing for Laboratory Personnel, The University of Texas MD Anderson Cancer Center, 2000
Ad Hoc Subcommittee Leader, Vaccine guidelines and availability planning, The University of Texas MD Anderson Cancer Center, 2000 - Present
Ad Hoc Subcommittee Leader, Vancomycin Resistant Organisms, The University of Texas MD Anderson Cancer Center, 2000 - Present
Ad Hoc Subcommittee Leader, Review of Modified TB Control Plan, The University of Texas MD Anderson Cancer Center, 2000
Member, Credential Committee, The University of Texas MD Anderson Cancer Center, 2000 - 2011
Ad Hoc Subcommittee Leader, Antibiotic Task Force, Automatic Stop & Vancomycin, The University of Texas MD Anderson Cancer Center, 1999
Ad Hoc Subcommittee Leader, Antibiotic Task Force, Synercid Restriction, The University of Texas MD Anderson Cancer Center, 1999
Ad Hoc Subcommittee Leader, Antibiotic Guidelines Task-force, The University of Texas MD Anderson Cancer Center, 1998
Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 1998
Chairman, Search for Clinical Microbiologist, The University of Texas MD Anderson Cancer Center, 1998 - 1999
Ad Hoc Subcommittee Leader, Update Aspergillosis Working Group, The University of Texas MD Anderson Cancer Center, 1997
Ad Hoc Subcommittee Leader, Recommendations for VRE Control, The University of Texas MD Anderson Cancer Center, 1997
Ad Hoc Subcommittee Leader, Recommendations for Changing Air Filters, The University of Texas MD Anderson Cancer Center, 1997
Member, LIS Steering Committee, The University of Texas MD Anderson Cancer Center, 1997 - 1998
Ad Hoc Subcommittee Leader, Fusarium Update, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Immunization Guidelines, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Fluconazole Update, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Immunization Guidelines, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Enteral Feeding Bag Reuse, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Enteral Feed Hang Time, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Fusarium Monitoring Update, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Immunization Guidelines, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Vancomycin Resistant Organisms, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Immunization Guidelines, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Enteral Feeding Bag Reuse, The University of Texas MD Anderson Cancer Center, 1996
Ad Hoc Subcommittee Leader, Recommendation on Utilization of Vaccine in Immunosuppressed Population, The University of Texas MD Anderson Cancer Center, 1995
Ad Hoc Subcommittee Leader, Vancomycin Resistant Organisms, The University of Texas MD Anderson Cancer Center, 1995
Member, Clinical Research Committee, The University of Texas MD Anderson Cancer Center, 1995 - 1998
Member, Co-Member, Institutional Review Board/Surveillance Committee, The University of Texas MD Anderson Cancer Center, 1995 - 2006
Member, Institutional Review Board, The University of Texas MD Anderson Cancer Center, 1995 - 2007
Ad Hoc Subcommittee Leader, Post-operative Precautions, Invasive Aspergillosis, The University of Texas MD Anderson Cancer Center, 1994
Ad Hoc Subcommittee Leader, CVC Exchanges over Guidewire, Update of Responsibilities of the Infection Control Officer, and Aerosolized Ribavirin Precautions, The University of Texas MD Anderson Cancer Center, 1994
Vice Chairman, Biosafety Committee, The University of Texas MD Anderson Cancer Center, 1994 - 1995
Faculty Senator, Senate Subcommittee - Education, The University of Texas MD Anderson Cancer Center, 1994 - 1999
Faculty Senator, Senate Subcommittee - Finance, The University of Texas MD Anderson Cancer Center, 1994 - 1999
Faculty Senator, Senate Subcommittee - Technology Transfer, The University of Texas MD Anderson Cancer Center, 1994 - 1999
Member, Quality Improvement/Quality Assurance Committee, The University of Texas MD Anderson Cancer Center, 1994
Ad Hoc Subcommittee Leader, T.B. Control Subcommittee, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Working Group, Blood Borne Precautions/Needle Sticks, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Working Group, Summary Assessment of RSV Outbreak, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Working Group, Action Plan for Tuberculosis Control, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Policy Review Subcommittee Report, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Working Group, Review of RSV Outbreak, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Subcommittee, Fungal Pathogens, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Subcommittee, Catheter Related Sepsis, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Working Group, RSV Outbreak Management Plan, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Working Group, Evaluation of Technol Mark, The University of Texas MD Anderson Cancer Center, 1993
Ad Hoc Subcommittee Leader, Working Group, Child Visitation Policy, The University of Texas MD Anderson Cancer Center, 1992
Ad Hoc Subcommittee Leader, Working Group, Safety of Aerosolized Ribavirin, The University of Texas MD Anderson Cancer Center, 1992
Ad Hoc Subcommittee Leader, Working Group, Plants and Fungal Infections, The University of Texas MD Anderson Cancer Center, 1992
Ad Hoc Subcommittee Leader, Subcommittee, Catheter Infections Subcommittee, The University of Texas MD Anderson Cancer Center, 1992
Ad Hoc Subcommittee Leader, Working Group, 24 hr. Isolator, The University of Texas MD Anderson Cancer Center, 1992
Ad Hoc Subcommittee Leader, Subcommittee, Fungal Infections, The University of Texas MD Anderson Cancer Center, 1992
Ad Hoc Subcommittee Leader, Working Group, Universal Precautions Plan, The University of Texas MD Anderson Cancer Center, 1992
Ad Hoc Subcommittee Leader, Working Group, Bone Marrow Transplantation Laboratory Policy, The University of Texas MD Anderson Cancer Center, 1992
Ad Hoc Subcommittee Leader, Working Group, Child Visitation, The University of Texas MD Anderson Cancer Center, 1992
Ad Hoc Subcommittee Leader, Working Group, Pharmacy Policy, The University of Texas MD Anderson Cancer Center, 1992
Member, Strategic Planning Committee, The University of Texas MD Anderson Cancer Center, 1992 - 1993
, Laboratory Medicine Advisory Committee to Search Committee for Head, The University of Texas MD Anderson Cancer Center, 1992 - 1994
Ad Hoc Subcommittee Leader, Working Group, Bone Marrow Transplantation Laboratory Evaluation, The University of Texas MD Anderson Cancer Center, 1991
Ad Hoc Subcommittee Leader, Working Group, Implementation of Universal Precautions Plan, The University of Texas MD Anderson Cancer Center, 1991
Ad Hoc Subcommittee Leader, Policy Review Subcommittee Report, The University of Texas MD Anderson Cancer Center, 1991
Ad Hoc Subcommittee Leader, Policy Review Subcommittee Report, The University of Texas MD Anderson Cancer Center, 1991
Ad Hoc Subcommittee Leader, Working Group, Revision of Universal Precautions Plan, The University of Texas MD Anderson Cancer Center, 1991
Ad Hoc Subcommittee Leader, Policy Review Subcommittee Report, The University of Texas MD Anderson Cancer Center, 1991
Ad Hoc Subcommittee Leader, Aspergillosis Report, The University of Texas MD Anderson Cancer Center, 1991
Ad Hoc Subcommittee Leader, Working Group, Revision of Universal Precautions Plan, Ma Working Group, Review of Blood Drawing/Central Lines, The University of Texas MD Anderson Cancer Center, 1991
Vice Chairman, Infection Control Subcommittee of the Executive Medical Staff, The University of Texas MD Anderson Cancer Center, 1991
Chairman, Blood Borne Pathogens Subcommittee, The University of Texas MD Anderson Cancer Center, 1991
Ad Hoc Subcommittee Leader, Working Group, Blood and Body Fluids, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Working Group, Infections associated with the Use of Medicinal Leeches, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Blood Precautions Labeling, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Working Group, Bone Marrow Lab Follow-up, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Working Group, Bone Marrow Lab Follow-up, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Working Group, Outpatient Surveillance, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Aspergillosis Subcommittee Report, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Catheter Related Infections Subcommittee, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Universal Precautions Subcommittee, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Working Group, Occurrence of Vancomycin Resistant Streptococci, The University of Texas MD Anderson Cancer Center, 1990
Ad Hoc Subcommittee Leader, Aspergillosis Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Catheter-Associated Infections Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Policy Review Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Working Group - Room Filter Change Out Analysis, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Policy Review Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Re-evaluation of ICU Baseline Rates Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Aspergillosis Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Working Group, HTLV-I Testing, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Examination of Mandatory Measles Vaccination Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Policy Review Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Aspergillosis Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Subcommittee to Re-Examine Child Visitation Policy, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Aspergillosis Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Subcommittee to Re-examine Child Visitation Policy, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Subcommittee on Universal Precautions, The University of Texas MD Anderson Cancer Center, 1989
Ad Hoc Subcommittee Leader, Policy Review Subcommittee, The University of Texas MD Anderson Cancer Center, 1989
Member, Product Standards and Evaluation Committee, The University of Texas MD Anderson Cancer Center, 1989 - 1991
Ad Hoc Subcommittee Leader, Policy Review Subcommittee, The University of Texas MD Anderson Cancer Center, 1988
Ad Hoc Subcommittee Leader, Subcommittee on Universal Precautions, The University of Texas MD Anderson Cancer Center, 1988
Ad Hoc Subcommittee Leader, Aspergillosis Subcommittee, The University of Texas MD Anderson Cancer Center, 1988
Ad Hoc Subcommittee Leader, Working Group, Reuse of Protective Eyewear, The University of Texas MD Anderson Cancer Center, 1988
Ad Hoc Subcommittee Leader, Policy Review Subcommittee, The University of Texas MD Anderson Cancer Center, 1988
Ad Hoc Subcommittee Leader, Working Group, Review of Blood Drawing/Central Lines, The University of Texas MD Anderson Cancer Center, 1988
Ad Hoc Subcommittee Leader, Working Group, Review of Blood Drawing/Central Lines, The University of Texas MD Anderson Cancer Center, 1988
Chairman, Policy Review Subcommittee, The University of Texas MD Anderson Cancer Center, 1988
Member, Infection Control committee, The University of Texas MD Anderson Cancer Center, 1988 - Present
Member, Microbial Review Subcommittee, The University of Texas MD Anderson Cancer Center, 1988 - 2003
Member, Institutional Biosafety Committee, The University of Texas MD Anderson Cancer Center, 1988 - 2003
Honors & Awards
| 1992 | AMA Physicians Recognition Award |
| 1975 | Rockefeller Foundation award |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2018. Basic and Collaborative Research Program in Mycology. Conference. Basic and Collaborative Research Program in Mycology. Houston, TX, US.
- 2018. Invasive Fungal Disease. Conference. Invasive Fungal Disease. Houston, TX, US.
- 2002. Developments in the Diagnosis and Management of Invasive Aspergillosis. Conference. Developments in the Diagnosis and Management of Invasive Aspergillosis. Houston, TX, US.
- 1999. Fusarium in the Hospital Environment. Conference. Fusarium in the Hospital Environment. Houston, TX, US.
- 1997. VRE Control Strategies. Conference. VRE Control Strategies. Houston, TX, US.
Formal Peers
- 2004. A novel reoviral oncolytic therapy for hematologic malignancy. Visiting. Houston, TX, US.
- 2004. Review of Plate Results, Microbiology-ID Rounds. Visiting. Houston, TX, US.
- 2004. Potential Effects of Tissue Phase Adaptation on the Diagnosis and Management of Invasive Aspergillosis. Visiting. Houston, TX, US.
- 2002. Development of a Novel Oncolytic Reoviral Therapy for Hematologic Malignancy. Visiting. Houston, TX, US.
- 2002. Aspergillus Diagnostics. Visiting. Houston, TX, US.
- 2001. Parasitology and Human Evolution. Visiting. Houston, TX, US.
- 2000. Point of care testing using dedicated phlebotomy teams. Invited. Houston, TX, US.
- 2000. Parasitology and Human Evolution. Visiting. Houston, TX, US.
- 1999. CMV Antigenemia vs Shell Vial utilization. Visiting. Houston, TX, US.
- 1999. Paleontology and Evolution. Visiting. Houston, TX, US.
- 1998. PCR Needs. Visiting. Houston, TX, US.
- 1998. Diagnosis of CMV Infection in Hematologic Malignancy. Visiting. Houston, TX, US.
- 1998. Diagnosis of CMV in BMT Patients. Visiting. Houston, TX, US.
- 1997. Optimizing Clinical Appropriateness of Blood Culturing. Invited. Houston, TX, US.
- 1997. Blood Culturing at UTMDACC - CNS and Mortality. Visiting. Houston, TX, US.
- 1997. Improving Diagnosis of Respiratory Viruses. Visiting. Houston, TX, US.
- 1997. CMV Antigenemia/Shell Vial/Culture. Visiting. Houston, TX, US.
- 1997. Review of Blood Culture - CNS and Costs. Visiting. Houston, TX, US.
- 1995. Microbiology of Neutropenic Patients. Invited. Houston, TX, US.
- 1995. Using the Clinical Microbiology Laboratory. Visiting. Houston, TX, US.
- 1994. Using the Clinical Microbiology Laboratory. Visiting. Houston, TX, US.
- 1992. The Use of Isolator Blood Culturing in Neutropenic Patients. Visiting. Houston, TX, US.
- 1991. Evaluation of Candida Antigen Testing. Visiting. Houston, TX, US.
- 1991. Pros and Cons in the Use of Quantitative Blood Culturing. Visiting. Houston, TX, US.
- 1991. Cladosporium and Allergic Reactions. Visiting. Houston, TX, US.
- 1991. Safety Practices in Handling Mycobacteria. Visiting. Houston, TX, US.
- 1990. Mycology Protocols and Veterinary Risk. Visiting. Houston, TX, US.
- 1990. The Use of Isolator Blood Culturing in Immunocompromised Patients. Visiting. Houston, TX, US.
- 1990. The Use of Isolator Blood Culturing in Immunocompromised Patients. Visiting. Houston, TX, US.
- 1990. H. pylori - A New Cause of Gastritis. Visiting. Houston, TX, US.
- 1989. Appropriate Laboratory Utilization. Visiting. Houston, TX, US.
- 1989. Controversies in Clinical Microbiology. Visiting. Houston, TX, US.
- 1989. Instruction of Safety Personnel and Graduate Students in Public Health to Clinical Microbiology. Visiting. Houston, TX, US.
- 1989. Optimization of Blood Culturing in Immunocompromised Patients. Visiting. Houston, TX, US.
- 1988. Nocardia. Visiting. Houston, TX, US.
- 1988. Nucardia. Visiting. Houston, TX, US.
- 1988. Actinomycetes. Visiting. Houston, TX, US.
- 1988. Actinomycetales in the Clinical Laboratory. Visiting. Houston, TX, US.
- 1988. Mycobacterium tuberculosis and M.leprae. Visiting. Houston, TX, US.
- 1988. Laboratory Testing of Mycobacteria. Visiting. Houston, TX, US.
- 1988. Clinical Mycobacteriology Overview. Visiting. Houston, TX, US.
- 1988. Haemophilus ducre. Visiting. Houston, TX, US.
- 1988. Haemophilus. Visiting. Houston, TX, US.
- 1988. Sphingomonas. Visiting. Houston, TX, US.
- 1988. Burkholderia. Visiting. Houston, TX, US.
- 1988. Pseudomonas. Visiting. Houston, TX, US.
- 1988. Bordetella. Visiting. Houston, TX, US.
- 1988. Legionella. Visiting. Houston, TX, US.
- 1988. Brucella. Visiting. Houston, TX, US.
- 1988. Instruction of Safety Personnel in Reference to Continuous Institutional Monitoring of Bioaerosols. Visiting. Houston, TX, US.
Grant & Contract Support
| Date: | 2007 - Present |
| Title: | Development of a Novel Reoviral Oncolytic Therapy |
| Funding Source: | Gulf Coast Medical Foundation |
| Role: | PI |
| Date: | 2007 |
| Title: | Development of a Novel Reoviral Oncolytic Therapy |
| Funding Source: | Living Legend Fund |
| Role: | PI |
| Date: | 2005 |
| Title: | Development of a Novel Reoviral Oncolytic Therapy for Pancreatic Cancer |
| Funding Source: | Cancer Fighters and various donors |
| Role: | PI |
| Date: | 2002 |
| Title: | Development of a Novel Reoviral Oncolytic Therapy for Hematologic Malignancy |
| Funding Source: | Cancer Therapeutic Development Program |
| Role: | Principle Investigator |
| Date: | 2001 |
| Title: | Development of Quantitative Molecular Assays for EBV Activity in Leukemia Patients |
| Funding Source: | Wolf Foundation |
| Role: | Principle Investigator |
| Date: | 2001 |
| Title: | Development of a Novel Reoviral Oncolytic Therapy for Hematologic Malignancy |
| Funding Source: | Cancer Therapeutic Development Program |
| Role: | Principle Investigator |
| Date: | 2000 - 2005 |
| Title: | Development of reverse transcribed PCR for quantitative assessment of type II EBV latency and correlation with treatment outcome |
| Funding Source: | |
| Role: | Principle Investigator |
| Date: | 2000 - 2001 |
| Title: | Clearance of VRE with Ramoplanin |
| Funding Source: | Supportive Care Grant |
| Role: | Collaborator |
| Date: | 2000 |
| Title: | Development of Quantitative PCR Methods for Virology |
| Funding Source: | Chromavision |
| Role: | Principle Investigator |
| Date: | 1999 |
| Title: | Evaluation of Automated Image Analysis in DFA Detection of CMV antigen |
| Funding Source: | Chromavision Inc |
| Role: | Principle Investigator |
| Date: | 1999 - 2006 |
| Title: | Development of Aspergillus Clinical/ Basic Research Working Group |
| Funding Source: | Divisional Developmental Funding |
| Role: | Co-Principle Investigator |
| Date: | 1998 |
| Title: | Cost and Benefit Urinalysis of Quantitative Blood Culturing |
| Funding Source: | Unrestricted Education Grant |
| Role: | Principle Investigator |
| Date: | 1998 |
| Title: | Seminars in Clinical Microbiology |
| Funding Source: | Unrestricted Education Grant |
| Role: | Principle Investigator |
| Date: | 1997 |
| Title: | Development of Quantitative Blood Culture, Threshold Values |
| Funding Source: | Wampole Laboratories |
| Role: | Principle Investigator |
| Date: | 1994 - 1996 |
| Title: | Development of Rapid Methods for Susceptibility Testing of Mycobacteria tuberculosis and Development of CMV Antigenemia testing |
| Funding Source: | University Cancer Foundation |
| Role: | Principle Investigator |
| Date: | 1993 - 1994 |
| Title: | Development and Characterization of IL6 Transfected Human Hybridoma Fusion Partners |
| Funding Source: | PRS Basic Research Grant |
| Role: | Principle Investigator |
| Date: | 1993 - 1994 |
| Title: | Evaluation of Gram Negative Endotoxin in an Antigen Detection Format using Saponin Lysates of Whole Blood |
| Funding Source: | Wampole Laboratories |
| Role: | Principle Investigator |
| Date: | 1992 - 1994 |
| Title: | Studies on Targeted Delivery of Antimycobacterial Drugs |
| Funding Source: | NIH |
| Role: | Co-PI |
| ID: | NIH RO1-AI31603-01 |
Selected Publications
Peer-Reviewed Articles
- Cho, SY, Wurster, ST, Matsuo, T, Jiang, Y, Tarrand, JJ, Kontoyiannis, DP. What Is the Prognostic Significance of Culture-Documented Breakthrough Invasive Pulmonary Aspergillosis in Patients with Hematological Malignancies? A Propensity Score-Adjusted Analysis. Journal of Fungi 11(9), 2025. e-Pub 2025. PMID: 41003169.
- Takahiro Matsuo, Sebastian Wurster, Tarrand J, Ying Jiang, Scott E Evans, Dimitrios P Kontoyiannis. Determinant of 30-Day Mortality of Pulmonary Legionellosis: Do Coinfections Matter?. Open Forum Infectious Diseases 11(9):ofae529, 2024. e-Pub 2024. PMID: 39319087.
- Takahiro Matsuo, Sebastian Wurster, Ying Jiang, Tarrand J, Dimitrios P Kontoyiannis. Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordance Between Responses of Skin Lesions and Systemic Outcomes. Open forum infectious diseases 11(2):ofae068, 2024. e-Pub 2024. PMID: 38379571.
- Matsuo, Takahiro, Wurster, Sebastian, Jiang, Ying, asaki, Koji, Tarrand J, Lewis, Russell E, Kontoyiannis, Dimitrios P. Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. Journal of antimicrobial chemotherapy 79(2):297–306, 2023. e-Pub 2023.
- Cheng GS, Crothers K, Aliberti S, Bergeron A, Boeckh M, Chien JW, Cilloniz C, Cohen K, Dean N, Dela Cruz CS, Dickson RP, Greninger AL, Hage CA, Hohl TM, Holland SM, Jones BE, Keane J, Metersky M, Miller R, Puel A, Ramirez J, Restrepo MI, Sheshadri A, Staitieh B, Tarrand J, Winthrop KL, Wunderink RG, Evans SE. Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc 20(3):341-353, 2023. e-Pub 2023. PMID: 36856712.
- Wurster S, Paraskevopoulos T, Toda M, Jiang Y, Tarrand JJ, Williams S, Chiller TM, Jackson BR, Kontoyiannis DP. Invasive mould infections in patients from floodwater- damaged areas after hurricane Harvey - a closer look at an immunocompromised cancer patient population. J Infect, 2022. e-Pub 2022. PMID: 35288118.
- Wurster S, Albert ND, Bharadwaj U, Kasembeli MM, Tarrand JJ, Daver N, Kontoyiannis DP. Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis. Front Immunol 13:838344, 2022. e-Pub 2022. PMID: 35251033.
- Udit Dhal, Rachel S Hicklen, Tarrand J, Dimitrios P Kontoyiannis. Cat Scratch Disease as a Mimicker of Malignancy. Open Forum Infect Dis 8(11):ofab500, 2021. e-Pub 2021. PMID: 34926712.
- Mori N, Szvalb AD, Adachi JA, Tarrand JJ, Mulanovich VE. Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer. BMC Infect Dis 21(1):1021, 2021. e-Pub 2021. PMID: 34587893.
- Axell-House DB, Wurster S, Jiang Y, Kyvernitakis A, Lewis RE, Tarrand JJ, Raad II, Kontoyiannis DP. Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer. J Fungi (Basel) 7(3), 2021. e-Pub 2021. PMID: 33802827.
- Sebastian Wurster, Prema Robinson, Nathaniel D Albert, Dimitrios P Kontoyiannis, Tarrand J, Marisa Goff, Muthulekha Swamydas, Jean K Lim, Michail S Lionakis. Protective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model. J Infect Dis 222(6):989-994, 2020. e-Pub 2020. PMID: 32432714.
- Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DP. Corrigendum: Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study. Open Forum Infect Dis 6(11):ofz458, 2019. e-Pub 2019. PMID: 31777755.
- Magira EE, Chemaly RF, Jiang Y, Tarrand J, Kontoyiannis DP. Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study. Open Forum Infect Dis 6(7):ofz247, 2019. e-Pub 2019. PMID: 31338382.
- Benanti GE, Brown ART, Shigle TL, Tarrand JJ, Bhatti MM, McDaneld PM, Shelburne SA, Aitken SL. Carbapenem versus Cefepime or Piperacillin-Tazobactam for the Empiric Treatment of Extended Spectrum β-lactamase Producing Escherichia coli Bacteremia in Patients with Hematologic Malignancy. Antimicrob Agents Chemother 63(2), 2019. e-Pub 2019. PMID: 30509935.
- Szvalb AD, Rolston KV, Mori N, Tarrand JJ, Mulanovich VE. Infections with the agent of 'kennel cough' in patients with cancer. J Infect 78(1):48-53, 2019. e-Pub 2019. PMID: 30048653.
- Magira EE, Jiang Y, Economides M, Tarrand J, Kontoyiannis DP. Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre. Mycoses 61(11):861-867, 2018. e-Pub 2018. PMID: 30015364.
- Fernández-Cruz A, Magira E, Heo ST, Evans S, Tarrand J, Kontoyiannis DP. Bronchoalveolar lavage fluid cytology in culture-documented invasive pulmonary aspergillosis in patients with hematologic diseases: analysis of 67 episodes. J Clin Microbiol 56(10), 2018. e-Pub 2018. PMID: 30021823.
- Folan SA, Marx KR, Tverdek FP, Raad I, Mulanovich VE, Tarrand JJ, Shelburne SA, Aitken SL. Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia. Open Forum Infect Dis 5(7):ofy167, 2018. e-Pub 2018. PMID: 30090838.
- Liu J, Mouhayar E, Tarrand JJ, Kontoyiannis DP. Fulminant Cryptococcus neoformans infection with fatal pericardial tamponade in a patient with chronic myelomonocytic leukaemia who was treated with ruxolitinib: Case report and review of fungal pericarditis. Mycoses 61(4):245-255, 2018. e-Pub 2018. PMID: 29280197.
- Economides MP, Ballester LY, Kumar VA, Jiang Y, Tarrand J, Prieto V, Torres HA, Kontoyiannis DP. Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often. J Infect 75(6):572-580, 2017. e-Pub 2017. PMID: 28919347.
- Le A, Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?. Antimicrob Agents Chemother 61(8), 2017. e-Pub 2017. PMID: 28584138.
- Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, Ciccone M, Kargin OA, Zhang X, Mur P, do Amaral NS, Chen M, Tarrand JJ, Lupu F, Ferrajoli A, Keating MJ, Vasilescu C, Yeung SJ, Calin GA. Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine 20:182-192, 2017. e-Pub 2017. PMID: 28465156.
- Nesher L, Tarrand J, Chemaly RF, Rolston KV. Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center. Support Care Cancer 25(4):1063-1069, 2017. e-Pub 2017. PMID: 27885468.
- Chaftari P, Chaftari AM, Adachi J, Hachem R, Raad S, Natividad E, Oliver N, Ellickalputhenpura B, Jiang Y, Tarrand J, Raad I. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control 45(3):e34-e39, 2017. e-Pub 2017. PMID: 28254252.
- DiPippo AJ, Tverdek FP, Tarrand JJ, Munita JM, Tran TT, Arias CA, Shelburne SA, Aitken SL. Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure. J Infect 74(3):243-247, 2017. e-Pub 2017. PMID: 27845153.
- Heo ST, Tatara AM, Jiménez-Ortigosa C, Jiang Y, Lewis RE, Tarrand J, Tverdek F, Albert ND, Verweij PE, Meis JF, Mikos AG, Perlin DS, Kontoyiannis DP. Changes in in vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a tertiary care cancer center (1999-2015). Clin Infect Dis. e-Pub 2017. PMID: 28379304.
- Abudayyeh A, Hamdi A, Abdelrahim M, Lin H, Page VD, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Oran B, Chemaly RF, Ahmed S, Abudayyeh I, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Rezvani K. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transpl Infect Dis. e-Pub 2016. PMID: 27862740.
- Aitken SL, Tarrand JJ, Deshpande LM, Tverdek FP, Jones AL, Shelburne SA, Prince RA, Bhatti MM, Rolston KV, Jones RN, Castanheira M, Chemaly RF. High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. Clin Infect Dis 63(7):954-8, 2016. e-Pub 2016. PMID: 27313265.
- Somogyi-Ganss E, Chambers MS, Lewin JS, Tarrand JJ, Hutcheson KA. Biofilm on the tracheoesophageal voice prosthesis: considerations for oral decontamination. Eur Arch Otorhinolaryngol. e-Pub 2016. PMID: 27400694.
- Stempel JM, Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Time-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients. Diagn Microbiol Infect Dis 85(3):391-3, 2016. e-Pub 2016. PMID: 27133559.
- Nigo M, Vial MR, Munita JM, Jiang Y, Tarrand J, Jimenez CA, Kontoyiannis DP. Fungal empyema thoracis in cancer patients. J Infect 72(5):615-21, 2016. e-Pub 2016. PMID: 26945845.
- Abudayyeh A, Hamdi A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Osama Gaber A, Salahudeen A, Oran B, Chemaly RF, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Winkelmayer WC, Rezvani K. Symptomatic BK Virus Infection Is Associated with Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. Am J Transplant. e-Pub 2015. PMID: 26608093.
- Jung DS, Farmakiotis D, Jiang Y, Tarrand JJ, Kontoyiannis DP. Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA. Emerg Infect Dis 21(11), 2015. e-Pub 2015. PMID: 26488845.
- Ferrajoli A, Ivan C, Ciccone M, Shimizu M, Kita Y, Ohtsuka M, D'Abundo L, Qiang J, Lerner S, Nouraee N, Rabe KG, Rassenti LZ, Van Roosbroeck K, Manning JT, Yuan Y, Zhang X, Shanafelt TD, Wierda WG, Sabbioni S, Tarrand JJ, Estrov Z, Radovich M, Liang H, Negrini M, Kipps TJ, Kay NE, Keating M, Calin GA. Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine 2(6):572-582, 2015. e-Pub 2015. PMID: 26288818.
- Han XY, Ihegword A, Evans SE, Zhang J, Li L, H' C, Tarrand JJ, El-Kweifi O. Microbiological and Clinical Studies of Legionellosis in 33 Patients with Cancer. J Clin Microbiol. e-Pub 2015. PMID: 25926494.
- Nesher L, Rolston KV, Shah DP, Tarrand JJ, Mulanovich V, Ariza-Heredia EJ, Chemaly RF. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 17(1):33-8, 2015. e-Pub 2015. PMID: 25546740.
- Li L, Tarrand JJ, Han XY. Four Cases of Catheter-related Infection by Methylobacterium radiotolerans: Microbiologic and Clinical Features. J Clin Microbiol. e-Pub 2015. PMID: 25631797.
- Farmakiotis D, Kyvernitakis A, Tarrand JJ, Kontoyiannis DP. Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation. Clin Microbiol Infect 21(1):79-86, 2015. e-Pub 2015. PMID: 25636931.
- Shelburne SA, Ajami NJ, Chibucos MC, Beird HC, Tarrand J, Galloway-Peña J, Albert N, Chemaly RF, Ghantoji SS, Marsh L, Pemmaraju N, Andreeff M, Shpall EJ, Wargo JA, Rezvani K, Alousi A, Bruno VM, Futreal PA, Petrosino JF, Kontoyiannis DP. Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One 10(11):e0139851, 2015. e-Pub 2015. PMID: 26556047.
- Rolston KV, Nesher L, Tarrand JJ. Current Microbiology of Surgical Site Infections in Patients with Cancer: A Retrospective Review. Infect Dis Ther 3(2):245-56, 2014. e-Pub 2014. PMID: 25403432.
- Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis 20(11):1833-40, 2014. e-Pub 2014. PMID: 25340258.
- Wang HL, Seo YH, LaSala PR, Tarrand JJ, Han XY. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses. Am J Clin Pathol 142(4):513-23, 2014. e-Pub 2014. PMID: 25239419.
- Chemaly RF, Dantes R, Shah DP, Shah PK, Pascoe N, Ariza-Heredia E, Perego C, Nguyen DB, Nguyen K, Modarai F, Moulton-Meissner H, Noble-Wang J, Tarrand JJ, LiPuma JJ, Guh AY, MacCannell T, Raad I, Mulanovich V. Cluster and Sporadic Cases of Herbaspirillum spp. Infections in Patients with Cancer. Clin Infect Dis. e-Pub 2014. PMID: 25216687.
- Shelburne SA, Lasky RE, Sahasrabhojane P, Tarrand JJ, Rolston KV. Development and Validation of a Clinical Model to Predict the Presence of β-lactam Resistance in Viridans Group Streptococci Causing Bacteremia in Neutropenic Cancer Patients. Clin Infect Dis 59(2):223-30, 2014. e-Pub 2014. PMID: 24755857.
- Galloway-Peña J, Sahasrabhojane P, Tarrand J, Han XY, Shelburne SA. GyrB Polymorphisms Accurately Assign Invasive Viridans Group Streptococcal Species. J Clin Microbiol. e-Pub 2014. PMID: 24899021.
- Sahasrabhojane P, Galloway-Peña J, Velazquez L, Saldaña M, Horstmann N, Tarrand J, Shelburne SA. Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients. Int J Antimicrob Agents. e-Pub 2014. PMID: 24721231.
- Farmakiotis D, Tarrand JJ, Kontoyiannis DP. The efficacy and tolerability of monotherapy with micafungin for candidemia and deep-seated candidiasis in adults with cancer. Antimicrob Agents Chemother. e-Pub 2014. PMID: 24637687.
- Anzalone CL, Cohen PR, Tarrand JJ, Diwan AH, Prieto VG. Nocardia yamanashiensis in an immunocompromised patient presenting as an indurated nodule on the dorsal hand. Tumori 99(4):156e-8e, 2013. e-Pub 2013. PMID: 24326852.
- Shah DP, Ghantoji SS, Shah JN, El Taoum KK, Jiang Y, Popat U, Hosing C, Rondon G, Tarrand JJ, Champlin RE, Chemaly RF. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J Antimicrob Chemother. e-Pub 2013. PMID: 23572228.
- Lewis RE, Cahyame-Zuniga L, Leventakos K, Chamilos G, Ben-Ami R, Tamboli P, Tarrand J, Bodey GP, Luna M, Kontoyiannis DP. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. e-Pub 2013. PMID: 23551865.
- Yilmaz M, Chemaly RF, Han XY, Thall PF, Fox PS, Tarrand JJ, De Lima MJ, Hosing CM, Popat UR, Shpall E, Champlin RE, Qazilbash MH. Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant. e-Pub 2013. PMID: 23503529.
- Rolston KV, Kapadia M, Tarrand J, Coyle E, Prince RA. Spectrum of Gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients. Int J Antimicrob Agents. e-Pub 2013. PMID: 23481658.
- McGrath DM, Barbu EM, Driessen WH, Lasco TM, Tarrand JJ, Okhuysen PC, Kontoyiannis DP, Sidman RL, Pasqualini R, Arap W. Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A. e-Pub 2013. PMID: 23345420.
- El Helou G, Hachem R, Viola GM, El Zakhem A, Chaftari AM, Jiang Y, Tarrand J, Raad II. Management of Rapidly Growing Mycobacteria Bacteremia in Cancer Patients. Clin Infect Dis. e-Pub 2012. PMID: 23254418.
- Shelburne SA, Tarrand J, Rolston KV. Review of Streptococcal Bloodstream Infections at a Comprehensive Cancer Care Center, 2000-2011. J Infect. e-Pub 2012. PMID: 23182968.
- Georgiadou SP, Tarrand J, Sipsas NV, Kontoyiannis DP. Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?. Mycoses. e-Pub 2012. PMID: 23170870.
- Chemaly RF, Hanmod SS, Rathod DB, Ghantoji SS, Jiang Y, Doshi A, Vigil K, Adachi JA, Khoury AM, Tarrand J, Hosing C, Champlin R. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood 119(12):2738-45; quiz 2969, 2012. e-Pub 2012. PMID: 22246027.
- Tarrand JJ, Lasala PR, Han XY, Rolston KV, Kontoyiannis DP. Dimethyl sulfoxide enhances the effectiveness of skin antiseptics and reduces the contamination rates of blood cultures. J Clin Microbiol. e-Pub 2012. PMID: 22378911.
- Shah DP, El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Tarrand JJ, Raad II, Chemaly RF. Characteristics and Outcomes of Pandemic 2009/H1N1 versus Seasonal Influenza in Children with Cancer. Pediatr Infect Dis J. e-Pub 2012. PMID: 22228234.
- Al Akhrass F, Al Wohoush I, Chaftari AM, Reitzel R, Jiang Y, Ghannoum M, Tarrand J, Hachem R, Raad I. Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS One 7(3):e32945, 2012. e-Pub 2012. PMID: 22427914.
- Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect. e-Pub 2011. PMID: 22101079.
- Al Akhrass F, Hachem R, Mohamed JA, Tarrand J, Kontoyiannis DP, Chandra J, Ghannoum M, Haydoura S, Chaftari AM, Raad I. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis 17(9):1651-8, 2011. e-Pub 2011. PMID: 21888790.
- Rolston KV, Mihu C, Tarrand JJ. Current microbiology of percutaneous endoscopic gastrostomy tube (PEG tube) insertion site infections in patients with cancer. Support Care Cancer 19(8):1267-71, 2011. e-Pub 2011. PMID: 21553315.
- Chemaly RF, Rathod DB, Sikka MK, Hayden MK, Hutchins M, Horn T, Tarrand J, Adachi J, Nguyen K, Trenholme G, Raad I. Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: A multi-state report. Am J Infect Control. e-Pub 2011. PMID: 21492963.
- Bidra AS, Tarrand JJ, Roberts DB, Rolston KV, Chambers MS. Antimicrobial efficacy of oral topical agents on microorganisms associated with radiated head and neck cancer patients: an in vitro study. Quintessence Int 42(4):307-15, 2011. e-Pub 2011. PMID: 21516276.
- Ramos ER, Reitzel R, Jiang Y, Hachem RY, Chaftari AM, Chemaly RF, Hackett B, Pravinkumar SE, Nates J, Tarrand JJ, Raad II. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: More than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med 39(2):245-51, 2011. e-Pub 2011. PMID: 21057308.
- Bhusal Y, Mihu CN, Tarrand JJ, Rolston KV. Incidence of fluoroquinolone-resistant and extended-spectrum ß-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States. Chemotherapy 57(4):335-8, 2011. e-Pub 2011. PMID: 21912115.
- Han XY, Tarrand JJ, Dickey BF, Esteva FJ. A case of Helicobacter pylori bacteremia with sepsis syndrome. J Clin Microbiol 48(12):4661-3, 2010. e-Pub 2010. PMID: 20861342.
- Martínez F, Tarrand J, Lichtiger B. Impact on patient outcome following transfusion of bacterially contaminated platelets: the M.D. Anderson Cancer Center experience. Am J Clin Pathol 134(2):207-12, 2010. e-Pub 2010. PMID: 20660322.
- Silva Lde P, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J, Han XY, Tarrand J, Ribeiro R, Gulbis A, Shpall EJ, Jones R, Popat U, Walker JA, Petropoulos D, Chiattone A, Stewart J, El-Zimaity M, Anderlini P, Giralt S, Champlin RE, de Lima M. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 95(7):1183-90, 2010. e-Pub 2010. PMID: 20410183.
- Morrow PK, Tarrand JJ, Taylor SH, Kau SW, Theriault RL, Hortobagyi GN, Broglio KR, Hahn KM. Effects of chronic hepatitis C infection on the treatment of breast cancer patients. Ann Oncol 21(6):1233-6, 2010. e-Pub 2010. PMID: 19875760.
- Rolston K, Mihu C, Tarrand J. ????Current microbiology of surgical site infections associated with breast cancer surgery ?. Wounds 22(5):132-5, 2010. e-Pub 2010. PMID: 25902178.
- Tarrand JJ, Keating MJ, Tsimberidou AM, O'Brien S, LaSala RP, Han XY, Bueso-Ramos CE. Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia. Cancer 116(4):880-887, 2010. e-Pub 2010. PMID: 20052729.
- Ben-Ami R, Lewis RE, Tarrand J, Leventakos K, Kontoyiannis DP. Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection. Antimicrob Agents Chemother 54(1):484-90, 2010. e-Pub 2010. PMID: 19858263.
- Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, Kontoyiannis DP. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115(20):4745-52, 2009. e-Pub 2009. PMID: 19634156.
- LaSala PR, Yarsa J, Nguyen DV, Han XY, Tarrand J. Evaluation of an abbreviated protocol for cytomegalovirus pp65 antigenemia testing. Am J Clin Pathol 131(4):526-31, 2009. e-Pub 2009. PMID: 19289588.
- Chen TM, Castaneda M, Wanitphakdeedecha R, Nguyen TH, Tarrand JJ, Soares MK. Precautions with gentian violet: skin marking made sterile, effective, and economical. Am J Infect Control 37(3):244-6, 2009. e-Pub 2009. PMID: 18922601.
- Vigil KJ, Mulanovich VE, Chemaly RF, Tarrand J, Raad II, Adachi JA. Severe parainfluenza virus type 2 supraglottitis in an immunocompetent adult host: an unusual cause of a paramyxoviridae viral infection. J Intern Med 265(3):397-400, 2009. e-Pub 2009. PMID: 19019183.
- Aisenberg GM, Aisenberg G, Torres HA, Torres H, Tarrand J, Safdar A, Bodey G, Chemaly RF. Herpes simplex virus lower respiratory tract infection in patients with solid tumors. Cancer 115(1):199-206, 2009. e-Pub 2009. PMID: 19090003.
- Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DP. Legionella pneumonia in cancer patients. Medicine (Baltimore) 87(3):152-9, 2008. e-Pub 2008. PMID: 18520324.
- O'Brien S, Ravandi F, Riehl T, Wierda W, Huang X, Tarrand J, O'Neal B, Kantarjian H, Keating M. Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy. Blood 111(4):1816-9, 2008. e-Pub 2008. PMID: 18039954.
- Keutgen X, Hachem R, Jiang Y, Pham-Williams T, Tarrand J, Raad I. A comparison of galactomannan-ELISA and a newly developed galactomannan-LATEX test in the serologic diagnosis of invasive aspergillosis in patients with hematologic malignancies. Eur J Clin Microbiol Infect Dis 26(9):655-8, 2007. e-Pub 2007. PMID: 17623114.
- Patah PA, Parmar S, McMannis J, Sadeghi T, Karandish S, Rondon G, Tarrand J, Champlin R, de Lima M, Shpall EJ. Microbial contamination of hematopoietic progenitor cell products: clinical outcome. Bone Marrow Transplant 40(4):365-8, 2007. e-Pub 2007. PMID: 17572714.
- Lasala PR, Segal J, Han FS, Tarrand JJ, Han XY. First reported infections caused by three newly described genera in the family xanthomonadaceae. J Clin Microbiol 45(2):641-4, 2007. e-Pub 2007. PMID: 17122001.
- Kontoyiannis DP, Chamilos G, Hassan SA, Lewis RE, Albert ND, Tarrand JJ. Increased culture recovery of Zygomycetes under physiologic temperature conditions. Am J Clin Pathol 127(2):208-12, 2007. e-Pub 2007. PMID: 17210526.
- Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 34(8):534-6, 2006. e-Pub 2006. PMID: 17015161.
- Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ, Champlin RE, Aguilera EA, Tarrand JJ, Raad, II. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 85(5):278-87, 2006. e-Pub 2006. PMID: 16974212.
- Safdar A, Rodriguez GH, Balakrishnan M, Tarrand JJ, Rolston KV. Changing trends in etiology of bacteremia in patients with cancer. Eur J Clin Microbiol Infect Dis 25(8):522-6, 2006. e-Pub 2006. PMID: 16896827.
- Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyiannis DP. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 91:986-9, 2006. e-Pub 2006. PMID: 16757415.
- Boktour M, Hanna H, Ansari S, Bahna B, Hachem R, Tarrand J, Rolston K, Safdar A, Raad I. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 106(9):1967-73, 2006. e-Pub 2006. PMID: 16565968.
- Chatzinikolaou I, Hanna H, Darouiche R, Samonis G, Tarrand J, Raad I. Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and bloodstream infection. J Clin Microbiol 44(5):1834-5, 2006. e-Pub 2006. PMID: 16672415.
- Yusuf SW, Ali SS, Swafford J, Durand JB, Bodey GP, Chemaly RF, Kontoyiannis DP, Tarrand J, Rolston KV, Yeh E, Raad II, Safdar A. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine (Baltimore) 85(2):86-94, 2006. e-Pub 2006. PMID: 16609347.
- Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma 6:393-8, 2006. e-Pub 2006. PMID: 16640816.
- Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer 41:2268-79, 2005. e-Pub 2005. PMID: 16143517.
- Chemaly RF, Torres HA, Hachem RY, Nogueras GM, Aguilera EA, Younes A, Luna MA, Rodriguez G, Tarrand JJ, Raad II. Cytomegalovirus pneumonia in patients with lymphoma. Cancer 104:1213-20, 2005. e-Pub 2005. PMID: 16078263.
- Kumashi P, Girgawy E, Tarrand JJ, Rolston KV, Raad II, Safdar A. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002). Medicine (Baltimore) 84:303-12, 2005. e-Pub 2005. PMID: 16148730.
- Han XY, Tarrand JJ, Infante R, Jacobson KL, Truong M. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol 43(9):4407-12, 2005. e-Pub 2005. PMID: 16145084.
- Han XY, Tarrand JJ, Rice DC. Oral Campylobacter species involved in extraoral abscess: a report of three cases. J Clin Microbiol 43(5):2513-5, 2005. e-Pub 2005. PMID: 15872299.
- Xiong Q, Hassan SA, Wilson WK, Han XY, May GS, Tarrand JJ, Matsuda SP. Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors. Antimicrob Agents Chemother 49(2):518-24, 2005. e-Pub 2005. PMID: 15673727.
- Tarrand JJ, Han XY, Kontoyiannis DP, May GS. Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery. J Clin Microbiol 43(1):382-6, 2005. e-Pub 2005. PMID: 15634998.
- Chatzinikolaou I, Hanna H, Hachem R, Alakech B, Tarrand J, Raad I. Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis 50(3):167-72, 2004. e-Pub 2004. PMID: 15541601.
- Lionakis MS, Bodey GP, Tarrand JJ, Raad II, Kontoyiannis DP. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin Microbiol Infect 10:922-5, 2004. e-Pub 2004. PMID: 15373888.
- Hanna H, Afif C, Alakech B, Boktour M, Tarrand J, Hachem R, Raad I. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 25(8):646-9, 2004. e-Pub 2004. PMID: 15357155.
- Hachem R, Graviss L, Hanna H, Arbuckle R, Dvorak T, Hackett B, Gonzalez V, Perego C, Tarrand J, Raad I. Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 25(5):391-4, 2004. e-Pub 2004. PMID: 15188844.
- Han XY, Tarrand JJ. Moraxella osloensis blood and catheter infections during anticancer chemotherapy: clinical and microbiologic studies of 10 cases. Am J Clin Pathol 121(4):581-7, 2004. e-Pub 2004. PMID: 15080311.
- Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 140(1):18-25, 2004. e-Pub 2004. PMID: 14706968.
- Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36:564-9, 2004. e-Pub 2004. PMID: 15370667.
- Safdar A, Chemaly RF, Perego CA, Gonzalez VR, Rolston KV, Raad II, Tarrand JJ, Callender DL. Hospitalization of an oncology patient suspected of having severe acute respiratory syndrome: a setup for an infection control quagmire at a comprehensive cancer center. Cancer 98:2738-9, 2003. e-Pub 2003. PMID: 14669300.
- Yadegarynia D, Tarrand J, Raad I, Rolston K. Current spectrum of bacterial infections in patients with cancer. Clin Infect Dis 37(8):1144-5, 2003. e-Pub 2003. PMID: 14523785.
- Han XY, Weinberg JS, Prabhu SS, Hassenbusch SJ, Fuller GN, Tarrand JJ, Kontoyiannis DP. Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. J Neurosurg 99(4):693-700, 2003. e-Pub 2003. PMID: 14567605.
- Caraway NP, Fanning CV, Stewart JM, Tarrand JJ, Weber KL. Coccidioidomycosis osteomyelitis masquerading as a bone tumor. A report of 2 cases. Acta Cytol 47(5):777-82, 2003. e-Pub 2003. PMID: 14526678.
- Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JJ, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore) 82(5):309-21, 2003. e-Pub 2003. PMID: 14530780.
- Torres HA, Bodey GP, Tarrand JJ, Kontoyiannis DP. Protothecosis in patients with cancer: case series and literature review. Clin Microbiol Infect 9(8):786-92, 2003. e-Pub 2003. PMID: 14616698.
- Han XY, Pham AS, Tarrand JJ, Rolston KV, Helsel LO, Levett PN. Bacteriologic characterization of 36 strains of Roseomonas species and proposal of Roseomonas mucosa sp nov and Roseomonas gilardii subsp rosea subsp nov. Am J Clin Pathol 120(2):256-64, 2003. e-Pub 2003. PMID: 12931556.
- Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS, Kontoyiannis DP. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 119(6):854-8, 2003. e-Pub 2003. PMID: 12817433.
- Mullen CA, Abd El-Baki H, Samir H, Tarrand JJ, Rolston KV. Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients. Support Care Cancer 11(5):321-5, 2003. e-Pub 2003. PMID: 12720076.
- Pham AS, De I, Rolston KV, Tarrand JJ, Han XY. Catheter-related bacteremia caused by the nocardioform actinomycete Gordonia terrae. Clin Infect Dis 36(4):524-7, 2003. e-Pub 2003. PMID: 12567313.
- Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XY. Diagnosis of invasive mold infection by real-time quantitative PCR. Am J Clin Pathol 119(1):38-44, 2003. e-Pub 2003. PMID: 12520695.
- Han XY, Pham AS, Tarrand JJ, Sood PK, Luthra R. Rapid and accurate identification of mycobacteria by sequencing hypervariable regions of the 16S ribosomal RNA gene. Am J Clin Pathol 118(5):796-801, 2002. e-Pub 2002. PMID: 12428802.
- Kontoyiannis DP, Reddy BT, Hanna H, Bodey GP, Tarrand J, Raad II. Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity. Infect Control Hosp Epidemiol 23:542-5, 2002. e-Pub 2002. PMID: 12269454.
- Torres HA, Reddy BT, Raad II, Tarrand J, Bodey GP, Hanna HA, Rolston KV, Kontoyiannis DP. Nocardiosis in cancer patients. Medicine (Baltimore) 81:388-97, 2002. e-Pub 2002. PMID: 12352633.
- Raad I, Tarrand J, Hanna H, Albitar M, Janssen E, Boktour M, Bodey G, Mardani M, Hachem R, Kontoyiannis D, Whimbey E, Rolston K. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol 23(9):532-7, 2002. e-Pub 2002. PMID: 12269452.
- Kandyil R, Maloney D, Tarrand J, Duvic M. Red nodule on the finger of an immunosuppressed woman. Arch Dermatol 138(5):689-94, 2002. e-Pub 2002. PMID: 12020236.
- Kontoyiannis DP, Reddy BT, Torres HA, Luna M, Lewis RE, Tarrand J, Bodey GP, Raad, II. Pulmonary candidiasis in patients with cancer: an autopsy study. Clin Infect Dis 34:400-3, 2002. e-Pub 2002. PMID: 11774088.
- Raad I, Hanna H, Osting C, Hachem R, Umphrey J, Tarrand J, Kantarjian H, Bodey GP. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol 23(1):41-3, 2002. e-Pub 2002. PMID: 11868892.
- Shaikh ZH, Osting CA, Hanna HA, Arbuckle RB, Tarrand JJ, Raad II. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer center. Journal of Hosp Infect 51:52-58, 2002. e-Pub 2002.
- Han XY, Pham AS, Nguyen KU, Smythe WR, Ordonez NG, Jacobson KL, Tarrand JJ. Pulmonary granuloma caused by Pseudomonas andersonii sp nov. Am J Clin Pathol 116(3):347-53, 2001. e-Pub 2001. PMID: 11554162.
- Ghosh S, Champlin RE, Ueno NT, Anderlini P, Rolston K, Raad I, Kontoyiannis D, Jacobson K, Luna M, Tarrand J, Whimbey E. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone Marrow Transplant 28(3):271-5, 2001. e-Pub 2001. PMID: 11535995.
- Konoplev S, Champlin RE, Giralt S, Ueno NT, Khouri I, Raad I, Rolston K, Jacobson K, Tarrand J, Luna M, Nguyen Q, Whimbey E. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant 27(8):877-81, 2001. e-Pub 2001. PMID: 11477447.
- Hanna H, Umphrey J, Tarrand J, Mendoza M, Raad I. Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 22(4):217-9, 2001. e-Pub 2001. PMID: 11379712.
- Nguyen Q, Estey E, Raad I, Rolston K, Kantarjian H, Jacobson K, Konoplev S, Ghosh S, Luna M, Tarrand J, Whimbey E. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis 32(4):539-45, 2001. e-Pub 2001. PMID: 11181115.
- Kontoyiannis DP, Tarrand J, Prince R, Samonis G, Rolston KV. Effect of fluconazole on agar invasion by Candida albicans. J Med Microbiol 50(1):78-82, 2001. e-Pub 2001. PMID: 11192509.
- Kontoyiannis DP, Sumoza D, Tarrand J, Bodey GP, Storey R, Raad, II. Significance of aspergillemia in patients with cancer: a 10-year study. Clin Infect Dis 31(1):188-9, 2000. e-Pub 2000. PMID: 10913421.
- Jacobson KL, Teira R, Libshitz HI, Raad I, Rolston KV, Tarrand J, Whimbey E. Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 30(6):965-9, 2000. e-Pub 2000. PMID: 10880318.
- Hanna H, Raad I, Gonzalez V, Umphrey J, Tarrand J, Neumann J, Champlin R. Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol 21(3):226-8, 2000. e-Pub 2000. PMID: 10738997.
- Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med 160(4):501-9, 2000. e-Pub 2000. PMID: 10695690.
- Rolston KV, Tarrand JJ. Pseudomonas aeruginosa--still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis 29(2):463-4, 1999. e-Pub 1999. PMID: 10476774.
- Nguyen Q, Champlin R, Giralt S, Rolston K, Raad I, Jacobson K, Ippoliti C, Hecht D, Tarrand J, Luna M, Whimbey E. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin Infect Dis 28(3):618-23, 1999. e-Pub 1999. PMID: 10194088.
- Narvios AB, Przepiorka D, Tarrand J, Chan KW, Champlin R, Lichtiger B. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients. Bone Marrow Transplant 22(6):575-7, 1998. e-Pub 1998. PMID: 9758346.
- Englund JA, Champlin RE, Wyde PR, Kantarjian H, Atmar RL, Tarrand J, Yousuf H, Regnery H, Klimov AI, Cox NJ, Whimbey E. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 26(6):1418-24, 1998. e-Pub 1998. PMID: 9636873.
- Jackow C, Puffer N, Hordinsky M, Nelson J, Tarrand J, Duvic M. Alopecia areata and cytomegalovirus infection in twins: genes versus environment?. J Am Acad Dermatol 38(3):418-25, 1998. e-Pub 1998. PMID: 9520023.
- Garcia R, Raad I, Abi-Said D, Bodey G, Champlin R, Tarrand J, Hill LA, Umphrey J, Neumann J, Englund J, Whimbey E. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol 18(6):412-6, 1997. e-Pub 1997. PMID: 9181397.
- Nicholson VA, Whimbey E, Champlin R, Abi-Said D, Przepiorka D, Tarrand J, Chan K, Bodey GP, Goodrich JM. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis. Bone Marrow Transplant 19(1):37-41, 1997. e-Pub 1997. PMID: 9012929.
- Hachem R, Raad I, Rolston KV, Whimbey E, Katz R, Tarrand J, Libshitz H. Cutaneous and pulmonary infections caused by Mycobacterium vaccae. Clin Infect Dis 23(1):173-5, 1996. e-Pub 1996. PMID: 8816149.
- Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I, Przepiorka D, Lewis VA, Mirza N, Yousuf H, Tarrand JJ, Bodey GP. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 22(5):778-82, 1996. e-Pub 1996. PMID: 8722930.
- Canpolat C, Culbert S, Gardner M, Whimbey E, Tarrand J, Chan KW. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients. Bone Marrow Transplant 17(4):589-93, 1996. e-Pub 1996. PMID: 8722360.
- Alvarez FE, Rogge KJ, Tarrand J, Lichtiger B. Bacterial contamination of cellular blood components. A retrospective review at a large cancer center. Ann Clin Lab Sci 25(4):283-90, 1995. e-Pub 1995. PMID: 7668812.
- Whimbey E, Couch R, Englund J, Andreeff M, Goodrich J, Raadi I, Tarrand JJ, Bodey G. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clinical Infectious Diseases 21:376-379, 1995. e-Pub 1995.
- Przepiorka D, Ippoliti C, Panina A, Goodrich J, Firalt S, van Besien K, Mehra R, Deisseroth AB, Andersson B, Luna M, Tarrand JJ, Champlin RE. Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone Marrow Transplantation 13:461-464, 1994. e-Pub 1994.
- Tarrand JJ Menard KP. Optimization of DSL for detection of metabolic heat from Escherichia coli. NATAS Proceedings:23, 1994. e-Pub 1994.
- Mehta RT, Keyhani A, McQueen TJ, Rosenbaum B, Rolston KV, Tarrand JJ. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrob Agents Chemother 37(12):2584-7, 1993. e-Pub 1993. PMID: 8109920.
- Laga EA, Jr, Toth BB, Rolston KV, Tarrand JJ. Evaluation of a rapid enzyme-linked immunoassay for the diagnosis of herpes simplex virus in cancer patients with oral lesions. Oral Surg Oral Med Oral Pathol 75(2):168-72, 1993. e-Pub 1993. PMID: 8381215.
- Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 11(8):675-82, 1992. e-Pub 1992. PMID: 1425725.
- Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 13(4):215-21, 1992. e-Pub 1992. PMID: 1593102.
- Yau JC, Dimopoulos MA, Huan SD, Tarrand JJ, Spencer V, Spitzer G, Meneghetti CM, Wallerstein RO, Andersson BS, LeMaistre CF. Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation. Eur J Haematol 47(5):371-6, 1991. e-Pub 1991. PMID: 1662140.
- Tarrand JJ, Guillot C, Wenglar M, Jackson J, Lajeunesse JD, Rolston KV. Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems. J Clin Microbiol 29(10):2245-9, 1991. e-Pub 1991. PMID: 1939578.
- Lal RB, Dhawan RR, Tarrand JJ, Ayoub EM, Ottesen EA. Lack of IgG4 antibody response to carbohydrate antigens in patients with lymphatic filariasis. Immunology 74(2):333-7, 1991. e-Pub 1991. PMID: 1748481.
- Friedman GC, Hartwick RW, Ro JY, Saleh GY, Tarrand JJ, Ayala AG. Allergic fungal sinusitis. Report of three cases associated with dematiaceous fungi. Am J Clin Pathol 96(3):368-72, 1991. e-Pub 1991. PMID: 1877534.
- Scott MG, Tarrand JJ, Crimmins DL, McCourt DW, Siegel NR, Smith CE, Nahm MH. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. II. IgG antibodies contain VH genes from a single VH family and VL genes from at least four VL families. J Immunol 143(1):293-8, 1989. e-Pub 1989. PMID: 2499631.
- Tarrand JJ, Scott MG, Takes PA, Nahm MH. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type B polysaccharide. Demonstration of three types of V regions and their association with H and L chain isotypes. J Immunol 142(7):2519-26, 1989. e-Pub 1989. PMID: 2494261.
- Scott MG, Crimmins DL, McCourt DW, Tarrand JJ, Eyerman MC, Nahm MH. A simple in situ cyanogen bromide cleavage method to obtain internal amino acid sequence of proteins electroblotted to polyvinyldifluoride membranes. Biochem Biophys Res Commun 155(3):1353-9, 1988. e-Pub 1988. PMID: 3178813.
- Vannier AM, Tarrand JJ, Murray PR. Mycobacterial cross contamination during radiometric culturing. J Clin Microbiol 26(9):1867-8, 1988. e-Pub 1988. PMID: 3183030.
- Tarrand JJ, Spicer AD, Groschel DH. Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother 30(6):852-5, 1986. e-Pub 1986. PMID: 3101586.
- Tarrand JJ, Groschel DH. Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis. J Clin Microbiol 21(6):941-6, 1985. e-Pub 1985. PMID: 3924952.
- Tarrand JJ, Groschel DH. Rapid, modified oxidase test for oxidase-variable bacterial isolates. J Clin Microbiol 16(4):772-4, 1982. e-Pub 1982. PMID: 7153330.
- Tarrand JJ, Krieg NR, Dobereiner J. A taxonomic study of the Spirillum lipoferum group, with descriptions of a new genus, Azospirillum gen. nov. and two species, Azospirillum lipoferum (Beijerinck) comb. nov. and Azospirillum brasilense sp. nov. Can J Microbiol 24(8):967-80, 1978. e-Pub 1978. PMID: 356945.
- Tarrand JJ, Krieg NR. A brief description of a new genus, Azospirillum gen nov and two species, Azospirillum lipoferum comb nov and Azospirillum brasilense sp nov. Internal J Bacterial Systematics, 1977. e-Pub 1977.
Invited Articles
- Tarrand JJ, Wagar E, Love G, Kontoyiannais D. Uncommon Invasive Mold Infections 16:5, 2011. e-Pub 2011.
- Tarrand JJ. Clinical Microbiology of Cancer Patients: Improving blood culture test appropriateness. Cancer Bulletin 45:86-91, 1993. e-Pub 1993.
Review Articles
- Han XY, Tarrand JJ, Escudero E. Infections by the yeast Kodomaea (Pichia) ohmeri: two cases and literature review. Eur J Clin Microbiol Infect Dis 23(2):127-30, 2004. e-Pub 2004. PMID: 14722784.
Other Articles
- Kassis C, Champlin RE, Hachem RY, Hosing C, Tarrand JJ, Perego CA, Neumann JL, Raad II, Chemaly RF Detection and Control of a Nosocomial Respiratory Syncytial Virus Outbreak in a Stem Cell Transplantation Unit: The Role of Palivizumab. Biol Blood Marrow Transplant 16(9):1265-71, 2010. PMID: 20304082.
- Ben-Ami R, Lewis R, Tarrand J, Leventakos K, Kontoyiannis D Antifungal activity of colistin against Mucorales sps in vitro and in a murine model of R. oryzae pulmonary infection. Antimicrob Agent Chemo 54:484-490.
- Martinez F, Tarrand J, Lichtiger B Impact on patients outcomes following transfusion of bacterially contaminated platelets: The M D Anderson Experiance. Am J Clinical.
- Aisenberg G, Torres H, Tarrand J, Safdar A, Bodey G, Chemaly R Herpes simplex virus lower respiratory tract infection in patients with solid tumors. Cancer 115:199-206, 2009.
- Vigil K, Mulanovich V, Chemaly R, Tarrand J, Raad II, Adachi J Severe parainfluenza virus type 2 supraglottitis in an immunocompetent adult host. An unusual cause of a paramyxoviridae viral infection. J Internal Medicien 265:394-400.
- Chen T, Castaneda M, Wanitphakdeedecha R, Nguyen T, Tarrand J, Soares M Precautions with gentian violate: Skin marking made sterile, effective, and economical. Am J Infection Control 37:244-246.
- Sipsas N, Lewis R, Tarrand J, Hachem R, Rolston K, Raad I, Kontoyiannis D Cndidemia in patients with hematologic malignancies in the era of new antifungal agents. Cancer 115:4745-4752, 2009.
- Vigil K, Adachi J, Aboufaycal H, Hachem R, Reitzel R, Jiang Y, Tarrand J, Chemaly R, Bodey G, Rolston K, Raad I Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infection Control 37:741-745.
- LaSala P Yarsa J, Nguyen D, Han X, Tarrand J Evaluation of an abbreviated protocol for cytomegalovirus pp65 abtugebenua testubg. Am J Clinical Pathology 131:526-531.
Abstracts
- Al Akhrass F, Al Wohoush I, Chaftari AM, Reitzel R, Jiang Y, Ghannoum M, Tarrand J, Hachem R, Raad I. Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS One 7(3):e32945, 2012. e-Pub 2012. PMID: 22427914.
- Tarrand JJ. When SARS hits home. Abstract. Association of Clinical Scientists, 2004. e-Pub 2004.
- Tarrand JJ, Kontoyiannis DP, Han XY, May GS. Culture incubation conditions affect the growth of Aspergillus spp. in an in vitro model system of tissue phase fungal growth. M-909, 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, 2002. e-Pub 2002.
- Miceli M, Kontoyiannis D, Tarrand J, Whimbey E, Jacobson K. Legionella pneumonia in the 1990’s in a testing cure cancer center. Infectious Diseases Society of America, 38th Annual, 2000. e-Pub 2000.
- Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, Kontoyiannis D. Culture yield from immunosuppressed cancer patients with invasive aspergillosis. Infectious Diseases Society of America , 38th Annual, 2000. e-Pub 2000.
- Raad II, Hanna HA, Alakech B, Chatzinikolaou I, Rolston KVI, Whimbey E, Tarrand JJ. Diagnosis of catheter-related bloodstream (CRBSI): Differential time to positivity (DPT) for short-term and long-term central venous catheters (CVC). 40th Interscience Conference on Antimicrobial Agents and Chemotherapy:Abstract #1426, 2000. e-Pub 2000.
- Rolston KV, Balakrishnan M, Elting LD, Tarrand JJ, Bodey GP. Is quantitative variation in cancer patients with bacteremic infections linked to severity of infection? . 40th Interscience Conference on Antimicrobial Agents and Chemotherapy:Abstract #729, 2000. e-Pub 2000.
- Chatzinikolaou I, Dholakia NA, Kontoyiannis D, Tarrand JJ, Rolston KVI. Rhodococcus spp. infection in cancer patients. 37th Annual Infectious Diseases Society of America:Abstract #128, 1999. e-Pub 1999.
- Samir H, Tarrand JJ, Ralston K. The changing face of candidemia in a pediatric population. 4th International Symposium on Febrile Neutropenia:Abstract #47, 1999. e-Pub 1999.
- Tiera R, Tarrand JJ, Rolston K. Bacteremia due to penicillin susceptible (PSSP) and penicillin non-susceptible Streptococcus pneumoniae (PNSP) in patients with cancer. 4th International Symposium on Febrile Neutropenia:Abstract #54, 1999. e-Pub 1999.
- Tarrand JJ Wengler M. Quantitative blood culture and coagulase negative staphylococci associated mortality. ASM, 1998. e-Pub 1998.
Book Chapters
- Krieg NR, Tarrand JJ. Taxonomy of the root-associated nitrogen-fixing bacterium Spirillum lipoferum. In: Limitations and Potentials for Biologic Nitrogen Fixation in the Tropics. Pleum Press, 317-333, 1978.
- Krieg NR, Tarrand JJ. Taxonomic Studies of Spirillum lipoferum. In: Genetic Engineering for Nitrogen Fixation. Pleum Press, 463-472, 1977.
Letters to the Editor
- Tarrand J, Sazama KJ, Lichtiger B. Reagent strips may not detect Staphylococcus epidermidis contamination of platelet concentrates. Arch Pathol Lab Med 128: 852-3, 2004.
- Han XY, Anderlini P, Tarrand J. Diagnosis and monitoring of primary cytomegalovirus infection by antigenemia test. Bone Marrow Transplant 30: 411, 2002.
Patents
- Diagnosis of Invasive Mold Infection. Patent Number: 10210349/UTXC:766USP1.
- Andersson BS, Tarrand J, Valdez BC. AZOLE PHARMACEUTICAL FORMULATIONS FOR PARENTERAL ADMINISTRATION AND METHODS FOR PREPARING AND USING THE SAME AS TREATMENT OF DISEASES SENSITIVE TO AZOLE COMPOUNDS. Patent Number: US 10,307,418 B2.
- Modified Reoviral Therapy. Patent Number: 10/211, 218.
- ANDERSSON, BORJE S, TARRAND, JEFFREY, VALDEZ, BENIGNO C. AZOLE PHARMACEUTICAL FORMULATIONS FOR PARENTERAL ADMINISTRATION AND METHODS FOR PREPARING AND USING THE SAME AS TREATMENT OF DISEASES SENSITIVE TO AZOLE COMPOUNDS. Patent Number: 2012/083138.
- Modified Reoviral Therapy. Patent Number: PCT/USO2/27089.
- Antiseptic Compositions. Patent Number: UTSC:901USP1:UTFC:901600.
- Tarrand JJ, Andersson BS. "Formulations of intraarticular pharmaceutical agents". Patent Number: UTSC.P1241US.P1.
Patient Reviews
CV information above last modified March 26, 2026